B
KRON

Bailard’s Kronos Bio KRON Stock Holding History

Bailard’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27,600
Closed -$47.5K – 743
2023
Q2 		$47.5K Sell
27,600
-100
-0.4% -$159 ﹤0.01% 677
2023
Q1 		$40.4K Buy
+27,700
New +$53.1K ﹤0.01% 705
2021
Q4 		– Sell
-53,000
Closed -$1.11M – 751
2021
Q3 		$1.11M Buy
53,000
+2,700
+5% +$58K 0.04% 254
2021
Q2 		$1.21M Buy
50,300
+19,300
+62% +$489K 0.04% 252
2021
Q1 		$907K Buy
+31,000
New +$908K 0.03% 272

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bailard's KRON Position: Q3 2023 in Review

Bailard sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 27,600 shares — an estimated $47.5K sold.

Bailard first reported a position in KRON in Q1 2021 and held it in 5 quarters. The position peaked at $1.21M in Q2 2021. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • Bailard reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • Bailard sold 27,600 Kronos Bio shares in Q3 2023, an estimated $47.5K.
  • Bailard first reported a position in Kronos Bio in Q1 2021 and held it in 5 quarters.
  • Bailard's Kronos Bio position peaked at $1.21M in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Bailard's 13F filing for Q3 2023, filed 24 Oct 2023.